Chiron Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$990K Sell
10,887
-50,854
-82% -$4.85M 0.33% 58
2024
Q3
$6.41M Buy
61,741
+15,043
+32% +$1.53M 2.25% 17
2024
Q2
$4.53M Buy
+46,698
New +$4.31M 1.78% 26
2023
Q4
Sell
-163,351
Closed -$11.6M 93
2023
Q3
$11.6M Buy
163,351
+42,669
+35% +$3.19M 4.91% 5
2023
Q2
$9.3M Buy
120,682
+105,433
+691% +$8.16M 2.61% 14
2023
Q1
$1.15M Buy
+15,249
New +$1.13M 0.21% 58
2022
Q4
Sell
-60,852
Closed -$4.28M 135
2022
Q3
$4.28M Buy
+60,852
New +$4.77M 0.86% 38

Other funds holding CL

Chiron Investment Management's CL Position: Q4 2024 in Review

Chiron Investment Management reduced its Colgate-Palmolive (CL) stake by 82% in Q4 2024, selling an estimated $4.85M and leaving 10,887 shares worth $990K. The position accounts for 0.33% of the portfolio, ranked #58.

Chiron Investment Management first reported a position in CL in Q3 2022 and has held it in 7 quarters since. The position peaked at $11.6M in Q3 2023. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Chiron Investment Management held 10,887 shares of Colgate-Palmolive worth $990K as of Q4 2024.
  • Chiron Investment Management sold 50,854 Colgate-Palmolive shares in Q4 2024, an estimated $4.85M.
  • Colgate-Palmolive made up 0.33% of Chiron Investment Management's portfolio in Q4 2024, its #58 holding.
  • Chiron Investment Management first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 7 quarters since.
  • Chiron Investment Management's Colgate-Palmolive position peaked at $11.6M in Q3 2023.
  • 1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Chiron Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.